Introduction {#s1}
============

*Helicobacter pylori* (*H. pylori*) is a Gram-negative bacterial pathogen responsible for human gastric diseases, including gastritis and peptic ulcers. It is also a major risk factor in the development of gastric cancer [@pone.0038528-Marshall1]--[@pone.0038528-Gerhard1]. In 1994, the World Health Organization listed *H. pylori* as a class I carcinogen.

Previous studies have shown that *H. pylori* has a high rate of homologous gene recombination. Phylogenetic analysis have subdivided *H. pylori* into distinct biogeographic populations and subpopulations with specific geographical distributions that reflect ancient human migrations. The studies also indicated that the East Asian type (hpEastAsia) is classified into at least three subtypes: East Asian (hspEAsia), Pacific (hspMaori) and native American (hspAmerind). The East Asia subtype (hspEAsia) may be related to the high incidence of gastric cancer in East Asia [@pone.0038528-Kraft1]--[@pone.0038528-Linz1]. A more recent study demonstrate the East Asian group appear to differ greatly from the European group in electron transfer and redox reactions, which suggest a model of adaptive evolution and selection through proteome diversification and modulation of translational fidelity [@pone.0038528-Mikihiko1].

A number of studies have focused on the *cag*- pathogenicity island encoded virulence apparatus that may play a critical role in *H. pylori* pathogenesis [@pone.0038528-Fischer1]--[@pone.0038528-Tegtmeyer1]. Importantly, almost all isolates from East Asia harbor the *cag*-PAI island. A few studies have shown that there are specific sequence characteristics shared among these islands in the various strains, which are responsible for causing different diseases [@pone.0038528-Olbermann1]--[@pone.0038528-Backert1]. This suggests that genome-wide analyses in various worldwide strains, especially for strains found in East Asia, are necessary. To date, there are thirty-two completed genomes and four draft genomes available on GenBank [@pone.0038528-Tomb1]--. Genome sizes among clinical isolates of *H. pylori* vary considerably, with some showing differences up to 25% [@pone.0038528-Raymond1], [@pone.0038528-Garcia1]. Comparative genomic profiling, using microarrays designed to cover entire genomes, is one strategy that can be used to obtain information about the variability between strains isolated from different patients and locations as well as to indicate horizontal gene transfer. Previously available commercial chips cover only one or two *H. pylori* genomes [@pone.0038528-Salama1]--[@pone.0038528-Nina1]. With more *H. pylori* genome sequences publicly available, it is possible to design high-density microarrays covering all of these fully sequenced genomes. During this study, an additional twenty-six strains associated with different clinical outcomes of various phylogeographic lineages were completely sequenced in the last two years. Additionally, several strains from other countries are also now undergoing sequencing. Here we describe the design and use of a high-density oligonucleotide microarray covering six sequenced *H. pylori* genomes. The performance of this microarray is evaluated, and we illustrate its utility for the hybridization of genomic DNA in order to compare eight uncharacterized *H. pylori* strains to the six established strains. We use this microarray to identify variable genomic regions among *H. pylori* strains isolated from patients with different gastroduodenal diseases in a Chinese patient population.

10.1371/journal.pone.0038528.t001

###### Characteristics of the 84 *H. pylori* strains studied.
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  Origin                   Clinical Diagnosis   No. of strains
  ----------------------- -------------------- ----------------
  Heilongjiang (n = 23)            GC                 12
                                   DU                 3
                                   GU                 3
                                   AG                 3
                                   SG                 2
  Shandong (n = 12)                GC                 12
  Hubei (n = 10)                   FD                 6
                                   GU                 2
                                   DU                 2
  Xi'an (n = 11)                   SG                 7
                                   DU                 1
                                  GDU                 3
  Yunnan (n = 10)                  SG                 5
                                   GU                 3
                                   DU                 2
  Jiangxi (n = 18)                 SG                 9
                                   GC                 9

Note: GC, gastric cancer. GU, gastric ulcer. AG, atrophic gastritis, DU, duodenal ulcer, GDU, gastroduodenal ulcer. FD, functional dyspepsia. SG, non-atrophic gastritis.

Materials and Methods {#s2}
=====================

H. Pylori Strains {#s2a}
-----------------

*H. pylori* is a well-known pathogen with much genetic variation; both host and bacterial factors may contribute to this fact. Strains isolated from different countries, different geographies, and even different families show genomic diversity [@pone.0038528-Linz2]. Therefore, from a genomic viewpoint, strain selection has been a critical issue for investigation of the pathogenic mechanism. In this study, we chose eight strains for microarray analysis. This included isolates from 2 patients with chronic superficial gastritis (HLJ220,HLJ215), 2 patients with atrophic gastritis (HLJ193,HLJ256), 2 patients with gastric ulcers (HLJ271,HLJ253), and 2 patients with gastric cancer (HLJ038,HLJ005). The strain numbers were encoded by our lab, Department of Diagnosis for Communicable Diseases, National Institute for Communicable Disease Control and Prevention, China CDC. They were all isolated from Heilongjiang province of China, which reports a high incidence rate of gastric cancer. We used PCR for investigating an additional 76 strains of disease specific genes, which were isolated from seven Chinese provinces. These included thirty-one gastric cancer strains (GC), six gastric ulcer strains (GU), one atrophic gastritis strain (AG), eight duodenal ulcer strains (DU), three gastroduodenal ulcer strains (GDU), six functional dyspesia strains (FD), and twenty-one non-atrophic gastritis strains (SG). Background information describing these strains is briefly listed in [table 1](#pone-0038528-t001){ref-type="table"}.

10.1371/journal.pone.0038528.t002

###### General features of the sequenced *H. pylori* genomes selected for microarray probe design.
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  strain    ACCESSION   length        origin       Clinical diagnosis
  -------- ----------- --------- ---------------- --------------------
  26695     AE000511    1667867         UK             Gastritis
  J99       AE001439    1643831        USA           Duodenal ulcer
  HPAG1     CP000241    1596366       Sweden       Atrophic gastritis
  P12       CP001217    1673813       German         Duodenal ulcer
  G27       CP001173    1652982   Italy, Tuscany    No known disease
  Shi470    CP001072    1608548        Peru            Gastritis

Ethics Statement {#s2b}
----------------

All patients involved have given informed consent for the samples to be used in historic or future studies. The consent was written, and ethics approval was obtained from the ethics committee of the Chinese Center for Disease Control and Prevention (China CDC) and the academic committee of the National Institute for Communicable Disease Control and Prevention, China CDC.

![Comparison of HLJ005, HLJ038, and 26695 based on strain specific genes of the six sequenced genomes.\
A. Comparison between HLJ005 and 26695. B. Comparison between HLJ038 and 26695. C. Comparison between HLJ038 and HLJ005. Green spots show inferred loss while orange dots show no changes in the original data. Red spots show inferred increase. Segment 1 on the X-axis: probes of 26695 strain specific genes. Segment 2: probes of G27 strain specific genes. Segment 3: probes of HPAG1 strain specific genes. Segment 4: probes of J99 strain specific genes. Segment 5: probes of P12 strain specific genes. Segment 6: probes of Shi470 strain specific genes.](pone.0038528.g001){#pone-0038528-g001}

![Comparison of HLJ005, HLJ038, and 26695 based on 0--100 kb of p12 genome.\
A. Comparison between HLJ005 and 26695. B. Comparison between HLJ038 and 26695. C. Comparison between HLJ038 and HLJ005. Green spots show inferred loss while orange dots show no changes in the original data. Red spots show inferred increase. The red rectangle indicates the predicted 5.2 kb absent region both in gastric cancer strain HLJ038 and HLJ005 based on the 0--100 kb of the reference P12 chromosome.](pone.0038528.g002){#pone-0038528-g002}

DNA Preparation {#s2c}
---------------

Genomic DNA was extracted by using the DNeasy Blood & Tissue Kit (QIAGEN) according to the manufacturer's instructions. The concentration of genomic DNA was adjusted to 120 ng/µl with nuclease-free water and to a volume of 40 µl. DNA was heated in a PCR machine (Biorad, USA) at 95°C for 10 min to obtain DNA fragments with sizes of 100 bp to 600 bp for genomic labeling. The results were visualized by 1% agarose gel electrophoresis.

![Genome comparison of eight *H. pylori* strains based on P12 reference sequence.\
Large variable regions were labeled with colored rectangles. Predicted gastric cancer strain specific regions were labeled with a red rectangle. General genomic variation among all strains was labeled with a green rectangle. A blue rectangle represents diverse regions obtained from comparison of gastric cancer strains and superficial gastritis strains. Corresponding coding proteins were briefly labeled at the bottom of each rectangle. GC vs SG denotes comparison between the two strains of gastric cancer and the two strains of superficial gastritis. DR, different region.](pone.0038528.g003){#pone-0038528-g003}

10.1371/journal.pone.0038528.t003

###### Predicted variable genomic region based on reference genome P12.
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  DR        Gene      start      end                  Gene description
  ------ ---------- --------- --------- ---------------------------------------------
  DR1                 49177     49869      adenine specific DNA methyltransferase
                      49866     50933      cytosine specific DNA methyltransferase
                      50930     52153             restriction endonuclease
                      52297     53568    type II R-M system restriction endonuclease
                      53568     56036       type II R-M system methyltransferase
  DR2                295040    303760      vacuolating cytotoxin VacA-like protein
  DR4      hsdS-1    448002    449183            type I R-M system S protein
           hsdM-1    449176    450807            type I R-M system M protein
                     452423    453496        integrase/recombinase XercD family
                     453578    454261               hypothetical protein
           virb6     454334    455632          VirB6 type IV secretion protein
                     455598    455876               hypothetical protein
                     455928    457328               hypothetical protein
                     457332    457577               hypothetical protein
                     457791    459272               hypothetical protein
                     459405    460469               hypothetical protein
                     460312    460803               hypothetical protein
                     460810    461832               hypothetical protein
                     462096    470522                   DNA methylase
            parA     470785    471441          chromosome partitioning protein
                     471523    471807               hypothetical protein
                     471839    473017               hypothetical protein
          virD2-1    473042    474955                     relaxase
                     475253    475567               hypothetical protein
                     475560    475841               hypothetical protein
          virD4-1    476105    477832              VirD4 coupling protein
                     477879    478391               hypothetical protein
                     478392    478682               hypothetical protein
                     478679    479134               hypothetical protein
          virB11-1   479131    480072          VirB11 type IV secretion ATPase
                     480072    480371               hypothetical protein
                     480368    480631               hypothetical protein
                     480624    480917               hypothetical protein
          virB10-1   480987    482252         VirB10 type IV secretion protein
          virB9-1    482252    483784          VirB9 type IV secretion protein
          virB8-1    483784    484953          VirB8 type IV secretion protein
          virB7-1    484957    485073          VirB7 type IV secretion protein
          virB3-1    489522    489788          VirB3 type IV secretion protein
          virB2-1    489789    490091          VirB2 type IV secretion protein
                     490088    490372               hypothetical protein
                     490433    491611               hypothetical protein
                     491618    491911               hypothetical protein
                     491931    492710               hypothetical protein
                     494743    496638               hypothetical protein
                     496664    497431               hypothetical protein
                     497441    497791             integral membrane protein
           virb6     454334    455632          VirB6 type IV secretion protein
                     455598    455876               hypothetical protein
                     455928    457328               hypothetical protein
                     457332    457577               hypothetical protein
  DR6      res-1     628179    631121      type III R-M system restriction enzyme
  DR8                1050977   1051564     serine/threonine kinase C-like protein
                     1051604   1052053     serine/threonine kinase C-like protein
                     1052213   1052728      serine/threonine phosphatase 2C-like
                                                           protein
  DR11    virB2-2    1396323   1396607         VirB2 type IV secretion protein
          virB3-2    1396619   1396882         VirB3 type IV secretion protein
                     1396894   1397130              hypothetical protein
          virB4-2    1397130   1399706         VirB4 type IV secretion ATPase
          virB7-2    1399703   1399843         VirB7 type IV secretion protein
          virB8-2    1399836   1400972         VirB8 type IV secretion protein
          virB9-2    1400969   1402624         VirB9 type IV secretion protein
          virB10-2   1402591   1403829        VirB10 type IV secretion protein
                     1403813   1405597              hypothetical protein
                     1405501   1406055              hypothetical protein
                     1406068   1407030              hypothetical protein
                     1407047   1407322              hypothetical protein
          virB11-3   1407327   1408271         VirB11 type IV secretion ATPase
                     1408268   1408786              hypothetical protein
          virD4-2    1408783   1411026             VirD4 coupling protein
                     1413163   1413633              hypothetical protein
                     1413603   1414406              hypothetical protein
                     1414480   1415145              hypothetical protein
                     1415123   1415401              hypothetical protein
                     1415334   1415765              hypothetical protein
                     1415750   1416160              hypothetical protein
                     1416165   1416794              hypothetical protein
                     1416897   1417178              hypothetical protein
                     1417399   1417788              hypothetical protein
                     1417796   1418086              hypothetical protein
                     1418215   1418466              hypothetical protein
                     1418394   1419248              hypothetical protein
                     1421131   1421259              hypothetical protein
          virD2-2    1421785   1423818                    relaxase
  DR12               1575820   1579728               type IIS R-M system
                                               restriction/modification enzyme
                     1580020   1582023              hypothetical protein
           res-4     1582157   1585066     type III R-M system restriction enzyme
           mod-5     1585069   1587111      type III R-M system methyltransferase

Note: DR, different region

Microarray Design, Labeling, Hybridization and Stripping {#s2d}
--------------------------------------------------------

A whole-genome CombiMatrix tiling CustomArray™ 90 K (Mukilteo, WA, USA) was used in this study. Combimatrix is a highly flexible platform that allows for the synthesis of in situ oligos (35mers) through the use of an electrochemistry-based method. This innovative technology also allows us to reuse the same microarray several times. Traditional cDNA microarrays involve large amounts of primer design and PCR for preparation of amplicon probes to be used for microarray printing. This process can be cumbersome and time consuming. Compared to all other platforms, including cDNA microarray, the Combimatrix drastically reduces fabrication and analytic costs. Thus, this process is more rapid and convenient. The platform has established a complete protocol for genomic analyses from sample labeling to data extraction [@pone.0038528-Michael1]--[@pone.0038528-Chen1].The array contained 90000 *in* *situ* synthesized oligonucleotide probes. In total, six sequenced genomes were taken for analysis. Genomic information for each strain is summarized in [Table 2](#pone-0038528-t002){ref-type="table"}. Genome alignments were performed by Combimatrix to obtain strain specific genes of each sequenced strain. We then took the whole genome of P12 as the reference sequence for tiling designation, which occupied about 70000 probes on the 90 k array. The sequences were first broken up into 100,000 bp blocks. We designed all possible probes for every 19 bp and selected the best one for each interval. At each position, a probe was extended until the Tm reached the desired Tm. Probes were then tested for quality, and the best probe (probe length 35∼40 mer) was chosen. Both strain-specific genes and plasmid genes were then chosen for tiling for the remaining 20000 probes based on the same criteria.

![Comparison of eight *H. pylori* strains based on strain specific genes of six sequenced strains.\
Large variable regions were labeled with colored rectangles. Predicted gastric cancer strain specific regions were labeled with a red rectangle. General genomic variations among all strains were labeled with a green rectangle. A blue rectangle represents diverse regions obtained from comparison of gastric cancer strains and superficial gastritis strains. Corresponding coding proteins were briefly labeled at the bottom of each rectangle. GC vs SG denotes comparison between the two strains of gastric cancer and the two strains of superficial gastritis.](pone.0038528.g004){#pone-0038528-g004}

10.1371/journal.pone.0038528.t004

###### Predicted variable genes based on strain specific genes of the six sequenced strains.
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  Strain             DR      Gene      start      end                    Gene description
  ---------------- ------ ---------- --------- --------- ------------------------------------------------
                    DR1     HP0440    457297    459330              DNA topoisomerase I (topA)
                            HP0441    459333    459333                    VirB4 homolog
  26695                     HP0442    461749    462015                 hypothetical protein
                            HP0443    462016    462318                 hypothetical protein
  strain                    HP0444    462315    461756                 hypothetical protein
                            HP0445    463954    464139                 hypothetical protein
  specific          DR2     HP0456    475056    475508                 hypothetical protein
                            HP0457    475826    476089                 hypothetical protein
  genes                     HP0458    476101    476337                 hypothetical protein
                            HP0459    476337    478913                virB4 homolog (virB4)
                            HP0460    479043    479531                 hypothetical protein
                            HP0461    479557    479649                 hypothetical protein
                            HP0462    480062    481159      type I restriction enzyme S protein (hsdS)
                            HP1366    1427688   1428959   type IIS restriction enzyme R protein (MBOIIR)
                    DR3     HP1367    1428975   1429757    type IIS restriction enzyme M1 protein (mod)
                            HP1368    1429744   1430607    type IIS restriction enzyme M2 protein (mod)
  G27               DR4               1046540   1048216                hypothetical protein
                                      1048432   1048734                hypothetical protein
  strain                              1053564   1054550                 competence protein
                                      1076345   1077382                hypothetical protein
  specific                            1081055   1082440                hypothetical protein
                                      1082440   1083642                hypothetical protein
  genes                               1083705   1084781               integrase-recombinase
                                                                             protein
                    DR5               1351624   1352001           adenine-specific DNA methylase
                                      1419432   1420331           adenine-specific DNA methylase
  HPAG1             DR6      HrgA      94738     95736                         HrgA
  strain            DR7               1410157   1412718                hypothetical protein
  Specific genes                                         
  J99               DR8    jhp0164    178219    179565             putative restriction enzyme
  strain                   jhp0165    179558    180778                 hypothetical protein
  Specific genes    DR9    jhp0929    1032025   1032477                hypothetical protein
                           jhp0930    1032591   1032833                hypothetical protein
                            topA_3    1032846   1034906                  topoisomerase I
                           jhp0932    1034961   1035431                hypothetical protein
                           jhp0933    1035401   1036204                hypothetical protein
                           jhp0934    1036277   1037296                hypothetical protein
                           jhp0935    1037343   1037885                hypothetical protein
                           jhp0936    1038083   1038616                hypothetical protein
                           jhp0937    1038613   1039878                hypothetical protein
  P12               DR10   virB2-2    1396323   1396607          VirB2 type IV secretion protein
  strain                   virB3-2    1396619   1396882          VirB3 type IV secretion protein
  Specific genes                      1396894   1397130                hypothetical protein
                           virB4-2    1397130   1399706           VirB4 type IV secretion ATPase
                           virB7-2    1399703   1399843          VirB7 type IV secretion protein
                           virB8-2    1399836   1400972          VirB8 type IV secretion protein
                           virB9-2    1400969   1402624          VirB9 type IV secretion protein
                           virB10-2   1402591   1403829          VirB10 type IV secretion protein
                                      1403813   1405597                hypothetical protein
                                      1405501   1406055                hypothetical protein
                                      1406068   1407030                hypothetical protein
                                      1407047   1407322                hypothetical protein
                           virB11-3   1407327   1408271          VirB11 type IV secretion ATPase
                                      1408268   1408786                hypothetical protein
                           virD4-2    1408783   1411026               VirD4 coupling protein
                                      1413163   1413633                hypothetical protein
                                      1413603   1414406                hypothetical protein
                                      1414480   1415145                hypothetical protein
                                      1415123   1415401                hypothetical protein
                                      1415334   1415765                hypothetical protein
                                      1415750   1416160                hypothetical protein
                                      1416165   1416794                hypothetical protein
                                      1416897   1417178                hypothetical protein
                                      1417399   1417788                hypothetical protein
                                      1417796   1418086                hypothetical protein
                                      1418215   1418466                hypothetical protein
                                      1418394   1419248                hypothetical protein
                                      1421131   1421259                hypothetical protein
                           virD2-2    1421785   1423818                      relaxase
                    DR11              1466136   1466765                hypothetical protein
                                      1470038   1471000    type II R-M system restriction endonuclease
                                      1470981   1471751    type II R-M system restriction endonuclease
                                      1479129   1479917                hypothetical protein
                                      1486667   1487452                hypothetical protein
                                      1487452   1489119                hypothetical protein
                                      1492159   1492494                hypothetical protein
                                      1507434   1507625                hypothetical protein
                                      1524027   1526738                  DNA polymerase I
                                      1528042   1530078       type IIS R-M system methyltransferase
                                      1555145   1556065                hypothetical protein
  Shi470            DR12              874998    876074             integrase/recombinase (xerD)
  strain                              876139    877341                 hypothetical protein
  Specific genes                      877341    878726                 hypothetical protein
                                      880915    882183                 hypothetical protein
                                      882184    883221                 hypothetical protein
                                      883375    891786                 hypothetical protein
                                      902243    903478                    ComB3 protein
                                      906132    908066                   topoisomerase I
                                      908059    910557                 DNA transfer protein
                                      910570    910830                 hypothetical protein
                                      910831    911133                 hypothetical protein
                                      911758    913038                 hypothetical protein
                                      913049    913813                 hypothetical protein
                                      913835    915454                 hypothetical protein

Note: DR, different region.

Four micrograms of heated DNA from each *H. pylori* strain was labeled with Cy5-ULS using the Kreatech ULS array CGH Labeling kit (EA-005, Kreatech, Netherlands) according to the manufacturer's instructions and then hybridized to the microarray. Experiments were performed according to CombiMatrix protocol. Microarrays were pre-hybridized with 6×SSPE containing 0.05% Tween-20, 5×Denhardt's solution, and 100 ng salmon sperm DNA for 30 min at 50°C. The Cy5-ULS labeled DNA fragments were then hybridized in the hybridizing solution (6×SSPE and 0.05% SDS) by denaturing at 95°C for 3 min and then incubating for 16 h at 50°C. Post-hybridization wash steps were 6×SSPET for 5 min at 50°C, 3×SSPET for 1 min, 0.5×SSPET for 1 min, and PBST for 1 min at room temperature. After hybridization and imaging, the microarray was stripped using CustomArray™ Stripping Solution. The well known sequenced strain 26695 and an additional eight strains from Heilongjiang province were hybridized to the chips.

![Gene content analysis of TFS4 and TFS3 in eighty-four *H. pylori* isolates by PCR.\
The presence of individual genes is indicated in red, and their absence in green. Non-specific amplicon is shown in black.](pone.0038528.g005){#pone-0038528-g005}

Microarray Scanning and Statistical Analysis {#s2e}
--------------------------------------------

Hybridized microarrays were covered with imaging solution and scanned with an Axon GenePix™ 4000B. All of the nine hybridizations were scanned at the same PMT value. The stripped microarray was also scanned with the same PMT gain value (475) to evaluate background noise as well as the stripping efficiency. Data was extracted by using Microarray_Imager_5.9.3 software. The foreground median of 635-nm signal intensities of each spot was used for the subsequent analysis. Genes that had at least five contiguous oligonucleotides with a minimum 635-nm intensity of 800 intensity units, and had at least one tile with 635-nm intensity \>1200 intensity units were defined as positive. We defined background signal intensity as the median signal intensity of all spots locations that did not have any oligos. QC-oligoB-AS-3 spots were also included in the background. QC-oligoB-AS-3 spots were CombiMatrix quality control oligonucleotides that occur 459 times on the array. Since QC-oligoB-AS-3 does not align to the *H. pylori* genome, these spots could be considered for background calculation for further analysis. On each of the arrays, the background signal was \<400 intensity units, indicating that our signal cutoff of 800 was sufficiently above background for identification. Based on the above described criteria for gene identification, information of probe location and corresponding hybridization signals were extracted for further analysis. For ease of analysis, all genes were separated into two independent files, one including genes located in the *H. pylori* P12 genome and another including strain specific genes in each of the other strains, which are named chromosome 1--6 (this also included P12 strain specific genes). Isolates of gastric cancer were represented as GC, isolates of gastric ulcers were represented as GU, isolates of chronic superficial gastritis were represented as SG, and isolates of atrophic gastritis were represented as AG. Signal comparison was performed between the two strains in GC, GU, SG, and AG. Comparison was also performed by GC vs GU, GU vs AG, GC vs SG, and AG vs SG. Signal ratios of two hybridized strains were log2 transformed and imported into a web tool ADaCGH, which was used for the analysis of microarray datasets to show gains and losses of genes between the two genomes. The data was centered and segmented in ADaCGH by employing a position-dependent segmentation algorithm CBS (circular binary segmentation) to partition data points into absent, present, and no change sequence segments [@pone.0038528-Diaz1], [@pone.0038528-Olshen1]. Chi-square was used to analyze the association of genes with disease by comparing one disease group (i.e., GC) with the other two groups (i.e., SG and GU), as well as to analyze the TFSS gene distributions among different disease groups. P value \<0.05 was considered significant.

10.1371/journal.pone.0038528.t005

###### Distribution of *hrg*A in different diseases.
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  Diseases    hrgA   Total  
  ---------- ------ ------- ----
  GC           25      8     33
  GU           5       2     7
  DU           4       4     8
  GDU          0       4     4
  SG           9      14     23
  AG           1       2     3
  FD           3       3     6
  Total        47     37     84

Note: GC, gastric cancer. GU, gastric ulcer. AG, atrophic gastritis, DU, duodenal ulcer GDU, gastroduodenal ulcer, FD, functional dyspepsia, SG, non-atrophic gastritis.

Microarray Data Deposition {#s2f}
--------------------------

MIAME compliant microarray data of this study has been deposited at the Gene Expression Omnibus database (GEO, <http://www.ncbi.nlm.nih.gov/geo/>) under series accession number GSE32107.

Validation of genes associated with diseases by PCR {#s2g}
---------------------------------------------------

The results for some variable genes found to be associated with diseases by microarray analysis were confirmed using gene-specific PCR. We preliminarily selected 25 such genes involved in two TFSS systems, a predicted 5.2 kb variable region, and an *hrgA* gene, which was reported to have a high occurrence rate in strains isolated from gastric cancer patients in East Asia. Specific primers were selected based on the sequences of these genes. To investigate the distribution of genes that were predicted as genomic distinctive regions, eighty-four strains were selected for PCR analysis of the 25 genes. A heatmap of type IV systems genes was created using Mev_4\_0-2.

Results {#s3}
=======

Microarray Hybridization and Statistical Analysis {#s3a}
-------------------------------------------------

In order to test whether the established *H. pylori* microarray analysis system can accurately predict genomic distinction, we first analyzed strains 26695, HLJ005, and HLJ038 based on strain specific genes and 0--100 kb of the reference P12 genome sequence. As shown in [Figure 1](#pone-0038528-g001){ref-type="fig"}, six segments on the X-axis represent strain specific genes of the six sequenced genomes. Probes of segment one are strain specific genes of 26695. When comparing the hybridization signal of gastric cancer strain HLJ005 to 26695 with the web tool ADaCGH, almost all of these genes were predicted to be absent in HLJ005 ([Figure 1](#pone-0038528-g001){ref-type="fig"} A). The same pattern was found in another gastric cancer strain HLJ038 ([Figure 1](#pone-0038528-g001){ref-type="fig"} B).When comparing HLJ005 and HLJ038, only some minor variable probes were found in the six segments ([Figure 1](#pone-0038528-g001){ref-type="fig"} C). These analyses indicate that this custom designed microarray platform accurately predicts gene absence or presence in different clinical *H. pylori* isolates. This was further validated by PCR to confirm a predicted 5.2 kb absent region both in gastric cancer strain HLJ038 and HLJ005 based on the 0--100 kb of the reference P12 chromosome ([Figure 2](#pone-0038528-g002){ref-type="fig"}).

Variable genes of the tested strains were first obtained based on the reference P12 genome sequence ([Figure 3](#pone-0038528-g003){ref-type="fig"}, [Table 3](#pone-0038528-t003){ref-type="table"}). Twelve genomic regions with the most variable tiles among the eight strains are marked by a rectangle. Predicted gastric cancer strain specific regions were labeled with a red rectangle according to the comparison of GC vs SG and GC vs GU. Seven such areas were acquired, and encoded proteins were listed in [Table 3](#pone-0038528-t003){ref-type="table"} (DR1, 3, 4, 6, 8, 9, 12). The number of these variable genes present in the group of gastric cancer strains was statistically higher than those for the GU and SG strains (P\<0.05). These regions mainly coded for proteins related to the type I R-M system, type II R-M system, type III R-M system, TFSS system, and hypothetical proteins. General genomic variations among all strains were labeled with a green rectangle. Seven such regions were identified (DR 1, 2, 4, 5, 7, 8, 11). No significant correlation was found for the unique absence or presence of TFS4 or TFS3. However, absence of both TFS3 and TFS4 system genes display significant variation comparing GC strains to GU, DU, or SG strains (P\<0.05). Among the 25 strains that are absent for these two systems, 17 strains are GC strains (68%). No significant variation was found for the association of any gene cluster with special geography. In addition, cagPAI was also labeled with a green rectangle for its diversity among reported strains (DR5). However, cagPAI were conserved among the tested strains of this study. The blue rectangle represents diverse regions obtained from comparison of gastric cancer strain with superficial gastritis strain (DR10). Some of the corresponding coding proteins were briefly labeled at the bottom of each rectangle. GC vs SG denotes comparison among the two strains of gastric cancer and the two strains of superficial gastritis.

Comparison of eight *H. pylori* strains based on strain specific genes of six sequenced strains is shown in [Figure 4](#pone-0038528-g004){ref-type="fig"}. Twelve large variable regions are labeled with rectangles, including five red rectangles denoting predicted gastric cancer strain specific regions (DR1, 3, 4, 5, 12), three blue rectangles denoting diverse regions obtained from comparison of gastric cancer strains and superficial gastritis strains (DR 9, 10, 11), and five green rectangles denoting common variable genes among all strains (DR 1, 2, 6, 7, 8). These predicted variable genes based on strain specific genes of the six sequenced strains were listed in [Table 4](#pone-0038528-t004){ref-type="table"}.

Gene Variation Confirmed by PCR {#s3b}
-------------------------------

To further validate the microarray results, we performed PCR to confirm a predicted 5.2 kb absent region both in gastric cancer strain HLJ038 and HLJ005 based on the 0--100 kb of the reference P12 chromosome ([Figure 2](#pone-0038528-g002){ref-type="fig"} A B). PCR results validated that the 5.2 kb region is absent in the two gastric cancer strains but present in 26695 (data not shown). As shown in [Figure 2C](#pone-0038528-g002){ref-type="fig"}, comparing 0--100 kb of HLJ005 and HLJ038 shows minor differences between the two GC strains. These scattered differing genes are suspected to be strain-specific genes of HLJ005 and HLJ038.

A heatmap of variable genes detected among the three *H. pylori* test strains was also confirmed using PCR. Green denotes absence of genes; red indicates presence of genes. The distinct regions of the three test strains were clustered with a dendrogram, which was constructed by hierarchical analysis of the presence or absence of genes. Amplification of some genes showing a weak PCR product band or a band of incorrect size are represented in black. One possible explanation for this is that sequence variation in these genes occurs in the primer binding region. The twenty variable genes of the TFSS3 and TFSS4 in the eight GC isolates observed by ADaCGH were confirmed by PCR, showing concordance with the microarray data. The prevalence of these genes in isolates from 76 additional patients was tested by PCR ([Figure 5](#pone-0038528-g005){ref-type="fig"}). These genes were found to be absent in 18 of 33 GC strains (55%). Other strains harbor two or more of these gene. These data support the association of the loss of these genes in isolates from GC patients.

Discussion {#s4}
==========

In the eight Chinese isolates studied by microarray, we found 14 significant variable regions when comparing GC isolates to SG or GU isolates based on the P12 reference genome ([Figure 3](#pone-0038528-g003){ref-type="fig"}, [Table 2](#pone-0038528-t002){ref-type="table"}). These regions mainly coded for proteins related to the type I R-M system (DR3), type II R-M system (DR1), type III R-M system (DR6, DR12), TFSS system (DR4, DR11), and hypothetical proteins (DR8). These findings are consistent to those of previous reports. Previous research found a remarkable variety of restriction-modification (R-M) systems in *H. pylori*. Bacteria utilize R-M systems through conjugative plasmids or bacteriophages as a defense against invasion by foreign DNA. Recently, restriction--modification systems have been reported to be associated with *H. pylori* virulence. The best understood R-M system is the type II R-M family. Type II R-M systems include two enymes: one is a restriction endonuclease which cleaves DNA within a specific 4--8-bp sequence, while another is a methyltransferase which can specifically methylate DNA at adenine or cytosine residues. Bacteria can protect DNA from cleavage through this mechanism [@pone.0038528-Xu1]--[@pone.0038528-Andres1]. We identified a number of variable genes involved in these restriction-modification systems among the microarray tested strains. The results indicate a strong correlation between *H. pylori* R-M system and pathogenesis of gastric cancer. Further investigations involved in functional analysis of the R-M system are very necessary to demonstrate the potential mechanism.

A previous Chinese study, performed by Han, Y. H. et al, also analyzed the genomic variation of *H. pylori* isolates from patients with gastroduodenal diseases [@pone.0038528-Han1]. They found two diverse regions in the *H. pylori* genome that corresponded to plasticity zones (PZ) 1 and 2. Our results are partially consistent with one diverse region of their findings. This region comprises genes from HP0424 to HP0462. However in our study, we only identified genes in these regions from HP0440 to HP0445 and HP0456 to HP0462. For diverse region 2 from HP0984 to HP1009, we have not observed wide variation among our strains except for a minor difference of HP0993 and HP0994, which are predicted to be absent in GC strains HLJ005 and HLJ038 compared to the SG strain HLJ220. In addition to these distinctions, we found the other diverse region among strains based on 26695 strain specific genes. They are from HP1366 to HP1368 and encode type IIS restriction enzyme related proteins. For the other genes that were found by Han, Y. H. et al, such as HP0447, HP0704, and jhp0918, they claimed that certain genotypes had higher prevalence of these genes in DU or GC groups than in CG groups, but this was not inspected in our microarray that studied eight Heilongjiang province strains. These discrepancies may be due to the differences in strain selection. It is also possible that technical differences contribute to the discrepancies observed. Another previous comparative genomic study reported that genes located in the plasticity zones such as jhp0947 and jhp0949 are associated with disease [@pone.0038528-Jonge1]--[@pone.0038528-Yamaoka1]. For these genes, we also detected a small scattered variable region among the eight microarray tested strains. But we have not performed PCR tests in more strains for these genes. In the future, we will follow this work up with systematic analysis. Despite these variable genes described above, we found that the *cag* PAI was significantly conserved in the eight tested isolates from Heilongjiang province, which is consistent with the fact that *cag* PAI is geographically diverse.

The distribution of genes of type-IV secretion systems in Chinese isolates were also investigated in detail. *H. pylori* have at least three type-IV secretion systems (TFSS). The first type IV secretion system gene cluster is located in the cag pathogenicity island, which mediates the injection of the toxin CagA and is thought to be the most important apparatus that contributes to pathogenesis. Several studies have described and discussed the role of the cag-pathogenicity island encoded type IV secretion system in *H. pylori* pathogenesis [@pone.0038528-Fischer1]--[@pone.0038528-Tegtmeyer1]. However, the potential mechanism for *cag* PAI induced cancer is still under known. The second gene cluster is involved in a *comB* locus that confers competence for DNA transformation [@pone.0038528-Karnholz1]. Recently, a third TFSS responsible for DNA conjugation has been demonstrated and discussed in various studies. This TFSS system helps *H. pylori* rapidly acquire new genetic features and adapt to changes in the environment [@pone.0038528-Janssen1]--[@pone.0038528-Kersulyte1]. We explored genes involving two such TFSS systems of P12 in our study. Consistent with previous studies, many genes in these systems are variably present ([Figure 5](#pone-0038528-g005){ref-type="fig"}). Although complete TFS3 or TFS4 type IV secretion systems were found in some strains (i.e., HLJ242), partial absence of type IV secretion system genes seem to be more common. None of the tested strains harbored the two TFSS system genes despite a possible failure to amplify *virB7-1*. All of our tested strains did not contain *virB7-1*; this is probably because the length of *virB7-1* is only 117 bp. Therefore, it is difficult to design a pair of primers that efficiently amplify this gene target. Although no significant correlation was found for the unique absence or presence of TFS4 or TFS3, absence of both TFS3 and TFS4 system genes displayed significant variation comparing GC strains to GU, DU, or SG strains (P\<0.05). It is intriguing that large proportions of GC strains in our study lost these two systems, which are reported to be involved in the transfer of genomic fragments and the restriction-modification system through a special mechanism. More thorough research is required to explore the potential function or mechanism for losing TFSS systems in GC isolates.

We also found one of the four genes with the 5.2 kb predicted variable segment, a gene encoding cytosine specific DNA methyltransferase, is present in 11 of 12 GC strains isolated from Shandong province (represented as YTC). This suggests that special genomic characteristics may exist in this group of strains. Based on the strain specific genes of the six sequenced genomes, several variable genes were identified including an *hrgA* gene ([Figure 4](#pone-0038528-g004){ref-type="fig"}, [Table 3](#pone-0038528-t003){ref-type="table"}, DR6), which has been previously reported to be a strain-specific gene that might be associated with gastric cancer among *H. pylori* isolates from Asian patients [@pone.0038528-Takafumi1]. For the distribution of *hrg*A in our 33 tested gastric cancer strains, 25 (76%) tested positive for the presence of this gene, which was higher than previously reported rates of prevalence (43%). 21 of the remaining 51 (41%) isolates of non-cancer patients were positive for the gene. There is no statistical significance for the distribution of hrgA in different diseases ([Table 5](#pone-0038528-t005){ref-type="table"}). There are many additional variable genes that were screened by microarray among the tested strains. Validating each of these genes one by one by PCR would be laborious and be contrary to the goals of a microarray-based experiment, which is rapid and high throughput genomic analysis. Since the custom HP 90 k tiling microarray has been well designed, established, and evaluated in this study, a greater number of strains need to be analyzed by this tool in order to gather more detailed and reliable information about which variable genes contribute to different disease status.

We initially tried to cover all sequenced strains for probe design. At the time, only six strains had completed genome maps online. P12 was selected as a major tiling reference sequence since it is the longest. Strain specific genes of an additional five strains were also tiled to search for possible differences among the tested strains. To quickly evaluate the accuracy of this array design, we initially hybridized a well known sequenced strain 26695 and two strains isolated from two gastric cancer patients in Heilongjiang province. Paired comparison of these strains for a 0--100 kb region based on the P12 reference genome revealed several regions with genetic variation. Specific primers were designed for these genes, and PCR validation was performed in 26695, HLJ005, and HLJ038. Of the 12 genes tested, 11 were consistent with the microarray prediction(data not shown). For the strain specific genes of the six sequenced strains, our results precisely predicted that all strain specific genes of 26695 are actually present in 26695 compared to HLJ005 and HLJ038. These results indicate that the designed microarray can provide an accurate analysis for exploring genomic diversity among different HP strains.

The aim of this study was to search for genomic characteristics that may contribute to various digestive diseases. Strain selection is one of the most important aspects of this study because genomic diversity exists among strains of different geographic origin. To eliminate this interference, we selected eight strains that originated from a northeast province of China. Heilongjiang province has one of the highest incidence rates of gastric cancer. Our results show that comparison of the strains with the same diseases (HLJ005 vs HLJ038) have less variation than the strains with different diseases, which indicates that it is reasonable to further investigate more paired strains with different clinical diseases.

With the rapid development of next generation sequencing technology and reduced costs, microarrays will be completely replaced by sequencing in the future. However, no one can predict how long this change will take. We believe, that because of its low cost, microarray technology will continue to play an important role in genomic and expression level analyses of bacterial pathogens for several years. It also has easy handling and rapid time saving advantages. The established in situ synthesized high density oligo tiling microarray was successfully utilized in this study and can be used as a high throughput analytic tool for comparative genomics of *H. pylori*. Results of our study promote further understanding of specific disease-associated genes that can serve as novel biomarkers for identification of gastroduodenal diseases.
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